# DESCRIPTION

- claim benefit of prior application

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- motivate c-Myc inhibition

## SUMMARY

- summarize invention aspects

## DETAILED DESCRIPTION

- introduce genetically modified Pseudomonas Aeroginosa Exotoxin A
- describe chimeric fusion protein embodiments
- explain method of delivering c-Myc inhibitor to nucleus
- define c-Myc inhibitor and its functions
- describe peptide and polypeptide terms and conservative substitutions

### 1) Alanine (A), Serine (S), Threonine (T);

- list conservative amino acid substitutions

### 6) Phenylalanine (F), Tyrosine (Y), Tryptophan (W).

- describe non-conservative amino acid substitutions
- discuss variant amino acid sequences
- define mammalian cells
- describe chimeric fusion protein
- outline pharmaceutical composition
- discuss administration of composition
- describe delivery vehicles and sustained-release systems

## Definitions

- define key terms

## DESCRIPTION OF EMBODIMENTS

- describe preferred features and embodiments

### Materials and Methods

- describe gene synthesis and cloning
- describe cell line culture and stable transduction
- describe protein purification and quantification
- describe various assays and experiments

## RESULTS AND DISCUSSION

- describe tPE-H1 and tPE-Omomyc
- show activity of tPE-H1 and tPE-Omomyc
- compare tPE-H1 and tPE-Omomyc to other cell targeting peptides
- discuss unexpected results of tPE-H1 and tPE-Omomyc
- summarize efficacy of tPE-H1 and tPE-Omomyc

